Journal article

Apicoplast isoprenoid precursor synthesis and the molecular basis of fosmidomycin resistance in Toxoplasma gondii

SC Nair, CF Brooks, CD Goodman, A Strurm, GI McFadden, S Sundriyal, JL Anglin, Y Song, SNJ Moreno, B Striepen

Journal of Experimental Medicine | ROCKEFELLER UNIV PRESS | Published : 2011

Abstract

Apicomplexa are important pathogens that include the causative agents of malaria, toxoplasmosis, and cryptosporidiosis. Apicomplexan parasites contain a relict chloroplast, the apicoplast. The apicoplast is indispensable and an attractive drug target. The apicoplast is home to a 1-deoxy-d-xylulose-5-phosphate (DOXP) pathway for the synthesis of isoprenoid precursors. This pathway is believed to be the most conserved function of the apicoplast, and fosmidomycin, a specific inhibitor of the pathway, is an effective antimalarial. Surprisingly, fosmidomycin has no effect on most other apicomplexans. Using Toxoplasma gondii, we establish that the pathway is essential in parasites that are highly ..

View full abstract

Grants

Awarded by National Institute of Allergy and Infectious Diseases


Funding Acknowledgements

This work was funded in part by grants from the National Institutes of Health to B. Striepen (AI084415 and AI64671), S.N.J. Moreno (AI068467), and Y. Song (AI088123). B. Striepen is a Georgia Research Alliance Distinguished Investigator and G. I. McFadden is an Australian Research Council Federation Fellow and a Howard Hughes Medical Institute International Research Scholar with support from the National Health and Medical Research Council of Australia.